Invesco LTD Schedule 13G passive stakes

Invesco Ltd. has reported beneficial ownership of 5.4% of Canaan Inc.'s American Depository Receipts, totaling over 606 million shares.

Invesco Ltd. has disclosed beneficial ownership of 5.5% of Atmus Filtration Technologies Inc.'s common stock as of June 30, 2026.

Invesco Ltd. has disclosed beneficial ownership of 1,650,643 shares, representing 7.4% of ArcBest Corp's common stock, as of June 30, 2026.

Invesco Ltd. has disclosed a beneficial ownership of 13,678,393 shares, representing 7.3% of the common stock of Allegro MicroSystems Inc.

Invesco Ltd. has disclosed beneficial ownership of 10,365,640 shares, representing 5.0% of the common stock of Alignment Healthcare Inc., as of June 30, 2026.

Filers confirm beneficial ownership of Invesco Ltd. common stock, with no new material changes indicated.

Invesco Ltd. has reported a 4.9% beneficial ownership in Microchip Technology Inc. as of March 31, 2026.

Invesco Ltd. has reported beneficial ownership of 5.2% of Microchip Technology Inc.'s common stock as of December 31, 2025.

Invesco Ltd. has reported beneficial ownership of 5.2% of Monolithic Power Systems Inc.'s common stock as of December 31, 2025.

Invesco Ltd. has reported beneficial ownership of 5.9% of Cognizant Technology Solutions Corp. common stock as of March 31, 2026.

Invesco Ltd. has reported beneficial ownership of 25,708,221 shares, representing 5.7% of Coca-Cola Europacific Partners PLC's common stock, as of December 31, 2025.

Invesco Ltd. has filed a Schedule 13G, reporting beneficial ownership of 0.1% of Herc Holdings Inc. common stock as of June 30, 2026.

Invesco Ltd. has filed a Schedule 13G reporting beneficial ownership of 20.6% of the Invesco Bloomberg Enhanced Fallen Angels ETF.

Invesco Ltd. has filed a Schedule 13G reporting a 15% beneficial ownership stake in Canaan Inc. American Depository Receipts.

Invesco Ltd. has filed a Schedule 13G disclosing a 0.2% beneficial ownership stake in TrueBlue Inc. as of March 31, 2026.

Invesco Ltd. has filed an amended Schedule 13G disclosing beneficial ownership of 3.7% of Ultra Clean Holdings Inc. common stock.

Invesco Ltd. has filed a Schedule 13G reporting a 5.0% beneficial ownership stake in Collegium Pharmaceutical Inc.

Invesco Ltd. has reported beneficial ownership of 10.1% of Amentum Holdings Inc. common stock as of April 30, 2026.

Invesco Ltd. has filed a Schedule 13G, reporting beneficial ownership of 305,115 shares, representing 2.0% of the outstanding class, in the Invesco Bloomberg Enhanced Fallen Angels ETF.

Invesco Ltd. has filed an amendment to its Schedule 13G, disclosing a 2.7% beneficial ownership stake in The Bancorp, Inc. as of March 31, 2026.

Invesco Ltd. has filed an amended Schedule 13G reporting beneficial ownership of 4,831,614 shares of XPO Inc. common stock.

Invesco Ltd. has filed a Schedule 13G reporting beneficial ownership of 4.7% of Western Alliance Bancorp common stock.

Invesco Ltd. has filed a Schedule 13G reporting beneficial ownership of 8.4% of USA Compression Partners LP's outstanding partnership interests.

Invesco Ltd. filed a Schedule 13G reporting beneficial ownership of 3.8% of Travel + Leisure Co. common stock.

Invesco Ltd. has filed a Schedule 13G reporting beneficial ownership of 6.5% of Sunoco LP's outstanding partnership interests.

Invesco Ltd. filed a Schedule 13G disclosing beneficial ownership of 500,655 shares of StepStone Group Inc. common stock.

Invesco Ltd. has filed a Schedule 13G reporting beneficial ownership of 5.6% of the State Street SPDR S&P Oil & Gas Exploration & Production ETF.

Invesco Ltd. has filed a Schedule 13G reporting a 6.0% beneficial ownership stake in Rambus Inc. common stock.

Invesco Ltd. has filed an amendment to its Schedule 13G, disclosing a 4.6% beneficial ownership stake in QuidelOrtho Corp.

Invesco Ltd. filed a Schedule 13G disclosing beneficial ownership of 1,003,391 shares of Paymentus Holdings Inc. common stock.